Hezong Science&Technology Co Current Assets
The Current Assets of Hezong Science&Technology Co (300477.SZ) as of Oct 8, 2026 is 433.21 M CNY. In the previous year, Current Assets was 2.05 B CNY — a change of -78.90% (lower).
Get this data via API
Financial Data API
Current Assets
433.21 MCNY
YoY
-78.90%
Last updated:
The Hezong Science&Technology Co Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 433.21 MCNY | -78.90% | |
| 2.05 BCNY | -56.57% | |
| 4.73 BCNY | +13.34% | |
| 4.17 BCNY | +40.31% | |
| 2.97 BCNY | +43.34% | |
| 2.07 BCNY | -14.78% | |
| 2.43 BCNY | -40.22% | |
| 4.07 BCNY | +66.21% | |
| 2.45 BCNY | +73.00% | |
| 1.42 BCNY | +18.78% | |
| 1.19 BCNY | +32.15% | |
| 902.01 MCNY | +22.84% | |
| 734.29 MCNY | +36.69% | |
| 537.20 MCNY | -2.01% | |
| 548.21 MCNY | +112.95% | |
| 257.43 MCNY | +25.96% | |
| 204.38 MCNY | +31.12% | |
| 155.87 MCNY | +37.50% | |
| 113.36 MCNY | +15.43% | |
| 98.20 MCNY | +19.68% | |
| 82.06 MCNY | — |
Hezong Science&Technology Co Stock analysis
Frequently Asked Questions about Hezong Science&Technology Co stock
Current Assets of Hezong Science&Technology Co is 433.21 M CNY in 2025.
Current Assets of Hezong Science&Technology Co changed from 2.05 B CNY to 433.21 M CNY, representing a -78.90% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Hezong Science&Technology Co since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Hezong Science&Technology Co historically and in real time.
Balance Sheet — Hezong Science&Technology Co
All Key Metrics — Hezong Science&Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth